These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Expression of polypeptides of human immunodeficiency virus-1 reverse transcriptase in Escherichia coli. Becerra SP, Kumar A, Wilson SH. Protein Expr Purif; 1993 Jun; 4(3):187-99. PubMed ID: 7686063 [Abstract] [Full Text] [Related]
13. Disruption of a salt bridge between Asp 488 and Lys 465 in HIV-1 reverse transcriptase alters its proteolytic processing and polymerase activity. Goobar-Larsson L, Bäckbro K, Unge T, Bhikhabhai R, Vrang L, Zhang H, Orvell C, Strandberg B, Oberg B. Virology; 1993 Oct 26; 196(2):731-8. PubMed ID: 7690504 [Abstract] [Full Text] [Related]
14. The p15 carboxyl-terminal proteolysis product of the human immunodeficiency virus type 1 reverse transcriptase p66 has DNA polymerase activity. Hafkemeyer P, Ferrari E, Brecher J, Hübscher U. Proc Natl Acad Sci U S A; 1991 Jun 15; 88(12):5262-66. PubMed ID: 1711222 [Abstract] [Full Text] [Related]
18. In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome. Wakefield JK, Jablonski SA, Morrow CD. J Virol; 1992 Nov 15; 66(11):6806-12. PubMed ID: 1383571 [Abstract] [Full Text] [Related]
19. Mutations of a conserved residue within HIV-1 ribonuclease H affect its exo- and endonuclease activities. Wöhrl BM, Volkmann S, Moelling K. J Mol Biol; 1991 Aug 05; 220(3):801-18. PubMed ID: 1714505 [Abstract] [Full Text] [Related]